Онкология
2237 статей · 70 журналов
Динамика публикаций
Журналы подкатегории (70)
- Blood Neoplasia · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- European Journal of Surgical Oncology · Elsevier (85)
- Cancer Treatment and Research Communications · Elsevier (83)
- The Lancet Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (80)
- Journal of Thoracic Oncology · Elsevier (80)
- International Journal of Gynecological Cancer · Elsevier (79)
- EJC Skin Cancer · Elsevier (76)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- The Journal of Liquid Biopsy · Elsevier (52)
- Leukemia Research · Elsevier (51)
- Cancer Letters · Elsevier (50)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (32)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (20)
- Intelligent Oncology · Elsevier (18)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Russia slashes federal cancer funding to spend on defence
- Iberdomide plus daratumumab and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (EXCALIBER-RRMM): an open-label, randomised, controlled, phase 3 trial
- Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial
- Assessment of comprehensiveness of national cancer control plans using a multiagent artificial intelligence model: a global analysis
- Zamtocabtagene autoleucel, a tandem CD20–CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study
- Neoadjuvant niraparib monotherapy for unresectable, homologous recombination deficiency-positive, high-grade serous ovarian cancer (NANT): a multicentre, single-arm, phase 2 trial
- Global uptake of essential cancer medicines with and without complex genomic diagnostics: a retrospective observational study
- Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial
- Global health expenditures on cancer control: a cross-sectional analysis
- Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer
- Development of the Children's Oncology Group long-term follow-up guideline for cancer genetics evaluation in childhood cancer survivors
- Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations
- Estimated global treatment costs for 31 cancer types by stage, year, and follow-up period: a systematic review and modelling study
- Armamentarium of scientific tools enough to win cancer fight in the Commonwealth
- Small island developing states and the Commonwealth
- Survival in patients with renal cell carcinoma and brain metastases: an update of the Renal Graded Prognostic Assessment
- A council of the willing for cancer in the Commonwealth
- Turning shared inheritance into shared action
- Addressing gaps in cancer care in the Caribbean
- Cancer in the Commonwealth: a Lancet Oncology Commission
- The Commonwealth's cancer moment
- From Commonwealth ambition to African action on cancer
- Activity and safety of first-line pumitamig plus nab-paclitaxel in triple-negative breast cancer: a single-arm, phase 1b/2 trial
- Co-targeting angiogenesis and immune checkpoints in breast cancer
- Kenya's new cancer treatment targets test health system capacity
- Mastering the role of radiotherapy in pancreatic ductal adenocarcinoma: who and why?
- Genomically matched targeted therapy for ovarian clear cell carcinoma
- Risovalisib for PIK3CA-mutated recurrent or persistent ovarian clear cell carcinoma: a single-arm, multicentre, phase 2 trial
- Türkiye Health Minister calls for stricter tobacco control measures
- Review recommends radical overhaul to multidisciplinary working in NHS cancer services